WHO Gives Emergency Use Authorisation To Moderna’s COVID Vaccine

The World Health Organization (WHO) on Friday listed the Moderna coronavirus vaccine for emergency use, adding the another shot to its arsenal in the fight against the coronavirus.

Moderna joins shots from Pfizer BioNTech, AstraZeneca-SK Bio, Serum Institute of India and Janssen on WHO’s list for emergency use of vaccines, according to The Hill.

According to Sputnik, in a statement, “Today, WHO listed the Moderna COVID-19 vaccine (mRNA 1273) for emergency use, making it the fifth vaccine to receive emergency validation from WHO.”

WHO experts recommend using the vaccine for patients over 18 years of age. According to WHO estimates, the drug is mRNA-based, it has an efficacy of 94.1 per cent.

The vaccine can be stored between -25oC and -15oC, but it can also be stored for up to 30 days at temperatures between 2°C and 8°C.

However, the approval of Moderna’s shot to WHO’s emergency use is a precondition for it to be a part of COVAX and also the program to disseminate shots to low-income countries.

It also allows countries to accelerate their own regulatory approval to import and administer the COVID-19 vaccine.

With the European Union following shortly after in January the U.S. granted emergency use authorization to the Moderna shot in December.

As the world works to ramp up its coronavirus vaccinations to significantly control the pandemic over a year it broke out in Wuhan, China, the authorization comes.

Facebook Comments